Initially developed for type 2 diabetes, these agents are now widely used to achieve significant weight loss in individuals with obesity or overweight with comorbidities
Research Findings Ipamorelin is a synthetic growth hormone secretagogue that functions through activation of the growth hormone secretagogue receptor (GHS-R1a)
Some animal studies have shown probiotics prevented weight gain and insulin resistance, and promoted the release of GLP-1 [8,9]
Dietary fiber optimization requires a balanced approach
Products like Leusynergy (leucine + resveratrol) or Sytrinol-LNA (leucine + nicotinic acid + nobiletin) synergistically activate AMPK, SIRT1, and PGC-1key pathways for mitochondrial biogenesis, fat oxidation, and glucose metabolism
Additionally, SMGT-GLP-1 offers cardiovascular protection by reducing the risk of heart disease , improving lipid profiles , and providing anti-inflammatory effects , further protecting vascular health